[Big Reveal] Secret Strategy Makes Investors "Very, Very Rich
Studies by Harvard, Vanderbilt, the U.S. Chamber of Commerce, Reuters, Fidelity and Deutsche Bank all confirm one simple strategy leads to outsized profits for investors.

Yet the elites in Washington want to ban this moneymaking method!

Join Alexander Green and Bill O'Reilly on June 9 at 8 p.m. ET to discover perhaps the greatest (yet controversial) profit strategy of our lifetimes.
>>>

IBT Insider Trading (International Biotechnology Trust)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £101,565.25
Insider Selling (Last 12 Months): GBX 0

International Biotechnology Trust Insider Trading History Chart

This chart shows the insider buying and selling history at International Biotechnology Trust by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

International Biotechnology Trust Share Price & Price History

Current Price: GBX 620
Price Change: +0.30 (1.20%)
As of 05/20/2022 01:00 AM ET

This chart shows the closing price history over time for IBT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward
Get the Details Now.

International Biotechnology Trust Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2022Patrick MaxwellInsiderBuy3,725GBX 589£21,940.25
4/1/2022Patrick MageeInsiderBuy2,500GBX 633£15,825
3/21/2022Katherine Cornish-BowdenInsiderBuy1,500GBX 644£9,660
1/12/2022Katherine Cornish-BowdenInsiderBuy1,500GBX 684£10,260
11/2/2021Patrick MageeInsiderBuy4,000GBX 735£29,400
8/5/2021Caroline GulliverInsiderBuy2,000GBX 724£14,480
12/21/2020Jim HorsburghInsiderBuy15,000GBX 849£127,350
9/15/2020Patrick MageeInsiderBuy3,500GBX 792£27,720
2/26/2020Caroline GulliverInsiderBuy2,500GBX 592£14,800
See Full Table
[Big Reveal] Secret Strategy Makes Investors "Very, Very Rich
Studies by Harvard, Vanderbilt, the U.S. Chamber of Commerce, Reuters, Fidelity and Deutsche Bank all confirm one simple strategy leads to outsized profits for investors.

Yet the elites in Washington want to ban this moneymaking method!

Join Alexander Green and Bill O'Reilly on June 9 at 8 p.m. ET to discover perhaps the greatest (yet controversial) profit strategy of our lifetimes.
>>>

SEC Filings (Institutional Ownership Changes) for International Biotechnology Trust (LON:IBT)

International Biotechnology Trust logo
International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
Read More on International Biotechnology Trust

Today's Range

Now: GBX 620
Low: 611
High: 634.52

50 Day Range

MA: GBX 639.12
Low: 573.16
High: 689

52 Week Range

Now: GBX 620
Low: 563
High: 773.25

Volume

34,064 shs

Average Volume

84,671 shs

Market Capitalization

£253.49 million

P/E Ratio

9.00

Dividend Yield

4.99%

Beta

N/A

Who are the company insiders with the largest holdings of International Biotechnology Trust?

International Biotechnology Trust's top insider shareholders include:
  1. Caroline Gulliver (Insider)
  2. Jim Horsburgh (Insider)
  3. Katherine Cornish-Bowden (Insider)
  4. Patrick Magee (Insider)
  5. Patrick Maxwell (Insider)
Learn More about top insider investors at International Biotechnology Trust.
This is the golden age of investing in artificial intelligence!
A.I. is going to be one of the dominant themes over the next decade, as companies automate their businesses and use A.I. to remain competitive.
Invest in this red-hot industry at pre-IPO prices.